Skip to main content
Equibles

FMR LLC

Position in GALT — Galectin Therapeutics Inc

CIK 315066 BOSTON, MA
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$60,973
+$24,741 QoQ
Shares Held
13,141
+1.2% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 98 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. GALT ranks #271 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in GALT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $60,973 13,141
2026-03-31 $36,232 12,987
2025-12-31 $53,276 12,807
2025-09-30 $53,877 12,707
2025-06-30 $26,756 12,681
2025-03-31 $13,261 10,870
2024-12-31 $2,349 1,821
2024-09-30 $500 182
2023-03-31 $6,720 3,200
2022-06-30 $5,240 4,000
2022-03-31 $3,260 2,025
2021-12-31 $93 45
2021-09-30 $174 45
2021-06-30 $3 1
2021-03-31 $3,255 1,500